======= PLXNB3 ======= == Gene Information == * **Official Symbol**: PLXNB3 * **Official Name**: plexin B3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5365|5365]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9ULL4|Q9ULL4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLXNB3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLXNB3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300214|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the plexin family. It functions as a receptor for semaphorin 5A, and plays a role in axon guidance, invasive growth and cell migration. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]. * **UniProt Summary**: Receptor for SEMA5A that plays a role in axon guidance, invasive growth and cell migration. Stimulates neurite outgrowth and mediates Ca(2+)/Mg(2+)-dependent cell aggregation. In glioma cells, SEMA5A stimulation of PLXNB3 results in the disassembly of F-actin stress fibers, disruption of focal adhesions and cellular collapse as well as inhibition of cell migration and invasion through ARHGDIA-mediated inactivation of RAC1. {ECO:0000269|PubMed:15218527, ECO:0000269|PubMed:20696765, ECO:0000269|PubMed:21706053}. |TIG| |Sema| |PSI| |Plexin cytopl| |Rho GDP-dissociation inhibitor binding| |negative regulation of lamellipodium assembly| |negative regulation of lamellipodium organization| |semaphorin receptor complex| |semaphorin-plexin signaling pathway involved in axon guidance| |semaphorin receptor activity| |semaphorin-plexin signaling pathway involved in neuron projection guidance| |cell-cell adhesion mediator activity| |negative regulation of plasma membrane bounded cell projection assembly| |regulation of lamellipodium assembly| |semaphorin-plexin signaling pathway| |regulation of lamellipodium organization| |negative regulation of GTPase activity| |positive chemotaxis| |positive regulation of axonogenesis| |positive regulation of endothelial cell proliferation| |regulation of endothelial cell proliferation| |regulation of cell shape| |positive regulation of cell morphogenesis involved in differentiation| |homophilic cell adhesion via plasma membrane adhesion molecules| |negative regulation of cell projection organization| |regulation of axonogenesis| |positive regulation of epithelial cell proliferation| |regulation of plasma membrane bounded cell projection assembly| |regulation of cell projection assembly| |cell chemotaxis| |protein domain specific binding| |cell-cell adhesion via plasma-membrane adhesion molecules| |negative regulation of cell migration| |axon guidance| |neuron projection guidance| |negative regulation of cell adhesion| |negative regulation of cell motility| |positive regulation of neuron projection development| |regulation of cell morphogenesis involved in differentiation| |negative regulation of cellular component movement| |negative regulation of locomotion| |regulation of epithelial cell proliferation| |positive regulation of neuron differentiation| |axonogenesis| |positive regulation of cell projection organization| |axon development| |cell morphogenesis involved in neuron differentiation| |negative regulation of hydrolase activity| |positive regulation of neurogenesis| |neuron projection morphogenesis| |regulation of GTPase activity| |plasma membrane bounded cell projection morphogenesis| |regulation of cell morphogenesis| |cell projection morphogenesis| |regulation of neuron projection development| |cell-cell adhesion| |cell part morphogenesis| |positive regulation of nervous system development| |positive regulation of cell development| |chemotaxis| |taxis| |cell morphogenesis involved in differentiation| |cell surface| |regulation of neuron differentiation| |neuron projection development| |regulation of cell adhesion| |regulation of plasma membrane bounded cell projection organization| |negative regulation of cellular component organization| |regulation of cell projection organization| |cell morphogenesis| |negative regulation of catalytic activity| |neuron development| |regulation of neurogenesis| |cellular component morphogenesis| |regulation of cell migration| |regulation of cell motility| |positive regulation of cell population proliferation| |regulation of nervous system development| |cell adhesion| |regulation of cell development| |biological adhesion| |regulation of cellular component biogenesis| |cell migration| |positive regulation of cell differentiation| |regulation of locomotion| |regulation of cellular component movement| |neuron differentiation| |regulation of anatomical structure morphogenesis| |cell motility| |localization of cell| |plasma membrane bounded cell projection organization| |negative regulation of molecular function| |cell projection organization| |positive regulation of cellular component organization| |regulation of hydrolase activity| |locomotion| |positive regulation of developmental process| |integral component of plasma membrane| |generation of neurons| |movement of cell or subcellular component| |regulation of cell population proliferation| |neurogenesis| |cell development| |positive regulation of multicellular organismal process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|1.7| |[[:results:exp187|proTAME 5μM R04 exp187]]|1.7| |[[:results:exp484|GSK-J5 1.5μM R08 exp484]]|2| ^Gene^Correlation^ |[[:human genes:s:slc6a17|SLC6A17]]|0.446| |[[:human genes:t:tyms|TYMS]]|0.427| |[[:human genes:t:tbc1d3|TBC1D3]]|0.425| |[[:human genes:c:cdc6|CDC6]]|0.425| |[[:human genes:t:ticrr|TICRR]]|0.42| |[[:human genes:p:pde4dip|PDE4DIP]]|0.42| |[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.417| |[[:human genes:k:kctd17|KCTD17]]|0.416| |[[:human genes:a:atp6v1a|ATP6V1A]]|0.413| |[[:human genes:c:col2a1|COL2A1]]|0.413| |[[:human genes:c:copg1|COPG1]]|0.411| |[[:human genes:z:znf655|ZNF655]]|0.409| |[[:human genes:t:tbc1d3f|TBC1D3F]]|0.409| |[[:human genes:p:psmb2|PSMB2]]|0.408| |[[:human genes:d:dock6|DOCK6]]|0.403| |[[:human genes:r:rpl7l1|RPL7L1]]|0.401| Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2266 * **Expression level (log2 read counts)**: -1.73 {{:chemogenomics:nalm6 dist.png?nolink |}}